Forma Therapeutics Holdings

Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Forma Therapeutics Holdings balance sheet

Report period2018 2019 2020 2021
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Forma Therapeutics Holdings cash flows

Report period2018 2019 2020 2021
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Forma Therapeutics Holdings multipliers

Report period2018 2019 2020 2021
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Forma Therapeutics Holdings profitability

Report period2018 2019 2020 2021
ROA
ROE
ROS
EBITDA Margin
Operating margin
Forma Therapeutics Holdings assets
Forma Therapeutics Holdings cash flows
Forma Therapeutics Holdings news
14.10.2022
Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.
Source: {source} pictogram ir.formatherapeutics.com
Pictogram next
08.05.2022
Forma Therapeutics Holdings' GAAP loss for 3 months of 2022 was $44.158 million, up 22.8% from $35.96 million in the previous year.
Source: {source} pictogram ir.formatherapeutics.com
Pictogram next
01.03.2022
Forma Therapeutics Holdings' GAAP loss for 2021 was $172.964 million, up 145.6% from $70.414 million in the previous year.
Source: {source} pictogram ir.formatherapeutics.com
Pictogram next
12.11.2021
Forma Therapeutics Holdings' GAAP loss for 9M 2021 was $122.839 million, up 2.9 times from $41.826 million in the prior year.
Source: {source} pictogram ir.formatherapeutics.com
Pictogram next
All Forma Therapeutics Holdings news
General information
Company nameForma Therapeutics Holdings
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472 617-679-1970
Mailing address500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472
Websitewww.formatherapeutics.com
Information disclosurewww.sec.gov